Rejuvel Bio-Sciences, Inc.
NUUU - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.08K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5,082.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.88 |
| Outstanding Shares | 50,818,525 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Rejuvel Bio-Sciences, Inc.
1 employees
CEO: Charles J. Scimeca
Rejuvel Bio-Sciences, Inc. is a development-stage firm operating globally, primarily involved in the production, distribution, and marketing of skincare products. Its main offering is a skin cream sold under the Rejuvel brand. Additional...